AACR Virtual Annual Meeting II: Understanding Racial Disparities in Cancer
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
Cancer is often described as a disease of old age. However, certain cancers have become increasingly prevalent among younger populations...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...